MedTech giant Stryker has entered into a definitive agreement to acquire all of the issued and outstanding ordinary shares of … continue reading “Stryker to Acquire Wright Medical”
Integra LifeSciences has agreed to acquire some of Tornier’s ankle and toe assets in the U.S., to satisfy anti-trust regulators over merger with Wright Medical.
The SALVATION™ external fixation system forms an integral part of Wright’s Limb Salvage product portfolio
Wright Medical Group, Inc., and Tornier N.V. are to merge in an all stock transaction with a combined equity value of approximately $3.3 billion.
Wright Medical’s newly launched system combines a low-profile implant design and seamless integration with PROPHECY® Pre-Operative Navigation Alignment Guides.
Wright Medical Group, Inc. has acquired Solana Surgical, LLC and entered into a definitive agreement to acquire OrthoPro, LLC (OrthoPro), both of which it describes as privately held, high growth extremity companies.
Wright Medical Group, Inc. is to acquire French ortho extremity company Biotech International for $80 million. It says this will significantly expand Wright’s direct sales channel in France and international distribution network and add Biotech’s complementary extremity product portfolio.
Wright Medical Group, Inc. has announced it received a “not approvable” letter from the FDA in response to its Pre-Market Approval application for Augment® Bone Graft for use as an alternative to autograft in hindfoot and ankle fusion procedures.
Transaction Transforms Wright Medical into High Growth Extremities and Biologics Pure Play and Expands Growth Opportunities for OrthoRecon Business
Purchase Price of $290 Million Cash
By integrating BioMimetics’ breakthrough biologics platform and pipeline into its extremities business, Wright Medical Group will hope to dominate the market, especially if the company’s Augment® bone graft gets the FDA PMA nod.
Wright Medical Group, Inc. has announced the full commercial launch of the ORTHOLOC™ 3Di Reconstruction Plating System for foot and ankle surgery. The system is to be made available this month in both the U.S. and international markets.
According to a press release issued by US Law firm Bernstein Liebhard LLP, FDA has received almost 17,000 adverse event reports from 2000-2011, associated with metal hip implants, such as the DePuy ASR and Pinnacle hip systems. An FDA panel has been in session for two days to discuss the situation.
Wright has launched its Claw® II Polyaxial Compression plating system which it claims offers foot and ankle surgeons the possibility of matching the implant to the patient’s circumstances.
Wright’s Prophecy® Inbone® Pre-op navigation alignment guide for ankle replacement surgery has gained 510(k) approval and is being launched on a limited basis in USA.
ORTHOLOC™ 3Di Ankle Fracture System provides innovative product solution for treating ankle fractures while QUICKDRAW™ Knotless Soft Tissue Fixation System establishes strong foundation in soft tissue fixation.
New CEO for Wright Medical Brings Solid Track Record of Shareholder Value Creation
David D. Stevens to Continue as Chairman
Company Temporarily Suspends Guidance as New CEO Transitions into Leadership Role